Federal contract award
75F40121C00119
THE COMMON PERCEPTION THAT A LABEL OF 'NATURAL' ENSURES SAFETY, THE UNPLEASANT EPISODES AND SIDE EFFECTS ASSOCIATED WITH PHARMACEUTICAL (SYNTHETIC) DRUGS, ALONG WITH THE LONG HISTORY OF USAGE OF BOTANICALS AS MEDICINES, HAVE RESULTED IN T
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST NO FEE |
| Obligations | $1.6M |
| Current contract value | $1.6M |
| Potential contract value / ceiling | $1.6M |
| Start date | Sep 17, 2021 |
| Current end date | Sep 16, 2025 |
| Potential end date | Sep 16, 2025 |
| Latest award activity | Dec 19, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 6 of 6 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Dec 19, 2025 | P00005 | $0 | THIS ADMIN MODS CORRECTS THE CLIN 3 PERIOD OF PERFORMANCE AND REPLACES A COR UNDER THE CONTRACT. |
| Jun 6, 2024 | P00004 | $0 | HOLISTIC APPROACH TO ADDRESS THE QUALITY AND SAFETY OF BOTANICAL DRUGS - IMPORTANCE OF CHEMICAL AND BIOSIMILARITIES - BAA PMQWP 338 |
| Sep 15, 2023 | P00003 | $399.5K | HOLISTIC APPROACH TO ADDRESS THE QUALITY AND SAFETY OF BOTANICAL DRUGS - IMPORTANCE OF CHEMICAL AND BIOSIMILARITIES - BAA PMQWP 338 |
| Jul 2, 2022 | P00002 | $600.0K | HOLISTIC APPROACH TO ADDRESS THE QUALITY AND SAFETY OF BOTANICAL DRUGS - IMPORTANCE OF CHEMICAL AND BIOSIMILARITIES - BAA PMQWP 338 |
| Apr 6, 2022 | P00001 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO INCORPORATE HHSAR 352.232-71, ELECTRONIC SUBMISSION OF PAYMENT REQUESTS (FEB 2022) AND FDA ELECTRONIC INVOICING AND PAYMENT REQUIREMENTS - INVOICE PROCESSING PLATFORM (IPP) (JAN 2022). |
| Sep 17, 2021 | 0 | $600.0K | THE COMMON PERCEPTION THAT A LABEL OF 'NATURAL' ENSURES SAFETY, THE UNPLEASANT EPISODES AND SIDE EFFECTS ASSOCIATED WITH PHARMACEUTICAL (SYNTHETIC) DRUGS, ALONG WITH THE LONG HISTORY OF USAGE OF BOTANICALS AS MEDICINES, HAVE RESULTED IN T |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.